AXINEA SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test - Argentina Medical Device Registration

Access comprehensive regulatory information for AXINEA SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test in the Argentina medical device market through Pure Global AI's free database. This IVD Registration Group A and B medical device is registered with Argentina's ANMAT (National Administration of Drugs, Food and Medical Technology). The device was registered on January 19, 2024.

This page provides complete registration details including product code (1716-246), brand name (AXINEA SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test), authorized representative information, registration type, and regulatory compliance data from the official Argentina ANMAT medical device database. Pure Global AI offers free access to Argentina's medical device registry, helping global MedTech companies navigate Argentina regulations efficiently.